Letter by Uretsky regarding article, "Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) trial"

Circulation. 2011 Apr 5;123(13):e398; author reply e399. doi: 10.1161/CIRCULATIONAHA.110.977751.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Angioplasty, Balloon, Coronary* / methods
  • Clinical Trials as Topic* / methods
  • Coronary Artery Bypass* / methods
  • Drug-Eluting Stents*
  • Humans
  • Paclitaxel / administration & dosage*
  • Treatment Outcome

Substances

  • Paclitaxel